EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of antiphospholipid antibody syndrome in pregnancy A randomized pilot trial comparing dalteparin to unfractionated heparin



Treatment of antiphospholipid antibody syndrome in pregnancy A randomized pilot trial comparing dalteparin to unfractionated heparin



Pharmacotherapy 23(10): 1368, October




(PDF 0-2 workdays service: $29.90)

Accession: 035980977

Download citation: RISBibTeXText



Related references

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. Journal of Obstetrics and Gynaecology Canada 26(8): 729-734, 2004

Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertility and Sterility 83(3): 684-690, 2005

A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions. American Heart Journal 151(1): 175-175, 2005

Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial. Circulation 111(11): 1390-1397, 2005

Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Annals of Internal Medicine 123(1): 1-9, 1995

Pharmacokinetics of low molecular weight heparin and unfractionated heparin in females with antiphospholipid antibody syndrome. Pharmacotherapy 20(10): 1272, October, 2000

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Annals of Internal Medicine 114(7): 545-551, 1991

Comparison of enoxaparin and dalteparin with unfractionated heparin in the treatment of non-ST elevated acute coronary syndrome. Journal of Ayub Medical College, Abbottabad 23(3): 60-63, 2013

Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thrombosis and Haemostasis 60(3): 407-410, 1988

Repeated fetal losses associated with antiphospholipid antibodies a collaborative randomized trial comparing prednisone with low dose heparin treatment. American Journal of Obstetrics & Gynecology 166(5): 1318-1323, 1992

A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Critical Care Medicine 27(10): 2224-2228, 1999

Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial. Journal of Thrombosis and Haemostasis 9(8): 1483-1492, 2012

Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin. Prescrire International 8(41): 77-80, 1999

Dalteparin versus unfractionated heparin for prophylactic anticoagulation during pregnancy. American Journal of Obstetrics & Gynecology 185(6 Supplement): S182, December, 2001

A randomized comparison of dalteparin versus unfractionated heparin during percutaneous coronary interventions. Journal of the American College of Cardiology 41(6 Supplement A): 68A-69A, March 19, 2003